GRADE Study expands results of major NIH-sponsored comparative study of glucose lowering medications in Type 2 diabetes
The study, which included more than 5,000 volunteers with Type 2 diabetes from diverse racial and ethnic groups, compared the treatments insulin glargine, liraglutide, glimepiride and sitagliptin.